Evidence map›Paper›PMID 21116186›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2011

Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization.

Adam W Carrico, Elise D Riley, Mallory O Johnson, Edwin D Charlebois, Torsten B Neilands, Robert H Remien, Marguerita A Lightfoot, Wayne T Steward, Lance S Weinhardt, Jeffrey A Kelly and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 2 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.Journal of acquired immune deficiency syndromes (1999) · 2011
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Adam W CarricoCenter for AIDS Prevention Studies, University of California, San Francisco, CA 94105, USA. adam.carrico@ucsf.edu
Elise D Riley
Mallory O Johnson
Edwin D Charlebois
Torsten B Neilands
Robert H Remien
Marguerita A Lightfoot
Wayne T Steward
Lance S Weinhardt
Jeffrey A Kelly
Mary Jane Rotheram-Borus
Stephen F Morin
Margaret A Chesney
San Francisco AIDS Foundation · USMedical College of Wisconsin · USUniversity of California, San Francisco · USColumbia University · USSan Francisco General Hospital · USUniversity of California, Los Angeles · US

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIVU10MH057615 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROTHERAM-BORUS, MARY J · 2001 to 2004
$5.2M
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIVU10MH057636 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE · PI EHRHARDT, ANKE A · 2001 to 2004
$3.5M
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIVU10MH057616 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MORIN, STEPHEN F · 2001 to 2004
$2.9M
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIVU10MH057631 · NIMH · MEDICAL COLLEGE OF WISCONSIN · PI KELLY, JEFFREY A. · 2001 to 2004
$2.2M
HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIVR01MH057616 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CHESNEY, MARGARET ANN · 1998 to 2000
$848k
FUNCTIONAL IMPACT OF NEUROBEHAVIORAL IMPAIRMENTS IN HIVR01MH057226 · NIMH · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI HEATON, ROBERT KERNACHAN · 1997 to 2001
$382k
NIMH NIH HHS P30 MH043520NIMH NIH HHS P30 MH058107NIMH NIH HHS P30-MH058107NIMH NIH HHS P30 MH062246NIMH NIH HHS P30-MH062246NIMH NIH HHS P30-MH43520NIMH NIH HHS P30-MH57226NIMH NIH HHS R01 MH057616NIMH NIH HHS U10 MH057615NIMH NIH HHS U10 MH057616NIMH NIH HHS U10 MH057631NIMH NIH HHS U10 MH057636NIMH NIH HHS U10-MH57615NIMH NIH HHS U10-MH57616NIMH NIH HHS U10-MH57631NIMH NIH HHS U10-MH57636
6 · The paper itself

Abstract

backgroundIn the era of antiretroviral therapy (ART), depression and substance use predict hastened HIV disease progression, but the underlying biological or behavioral mechanisms that explain these effects are not fully understood.

methodsUsing outcome data from 603 participants enrolled in a randomized controlled trial of a behavioral intervention, binary logistic and linear regression were employed to examine whether inconsistent patterns of ART utilization partially mediated the effects of depression and substance use on higher HIV viral load over a 25-month follow-up.

resultsElevated affective symptoms of depression independently predicted ART discontinuation [adjusted odds ratio = 1.39, 95% confidence interval (CI) = 1.08 to 1.78], and use of stimulants at least weekly independently predicted intermittent ART utilization (adjusted odds ratio = 2.62, 95% CI = 1.45 to 4.73). After controlling for the average self-reported percentage of ART doses taken and baseline T-helper (CD4) count, elevated depressive symptoms predicted a 50% higher mean viral load, and weekly stimulant use predicted a 137% higher mean viral load. These effects became nonsignificant after accounting for inconsistent patterns of ART utilization, providing evidence of partial mediation.

conclusionsInconsistent patterns of ART utilization may partially explain the effects of depression and stimulant use on hastened HIV disease progression.

Indexed as

Disease ProgressionDrug MonitoringAdultAgedAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveDepressionFemaleHIV InfectionsHumansMaleMiddle AgedRisk FactorsSubstance-Related DisordersAnti-HIV Agents

Identifiers

PMID21116186
PMCPMC3494991
OpenAlexW2017042373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.